Digital Endpoints in Clinical Trials for Neurology: Benefits and Impediments to Adoption

In addition to the pandemic, the digitization of healthcare is rapidly shifting clinical trials from analog to hybrid or fully decentralized clinical trials, catalyzing the development and implementation of digital health technologies to support clinical research.

Digital endpoints not only support the decentralization of clinical trials but also provide a means to collect more sensitive, high-frequency data while reducing trial costs and improving overall efficiency. 

Below, we discuss the use of digital endpoints in clinical trials for neurology, highlighting the benefits and impediments to adoption.